Select Page

Researcher from University of the West of Scotland, Isla Scullion, is recruiting for a study relating to pets and early-onset dementia. Read more about Isla’s research and how to get involved below. 

The purpose of this study is to investigate whether owning pets is a positive or negative for people with early-onset dementia. The relationship between people with this type of dementia and pets hasn’t been the focus of much research in the past so this study will aim to look further into this. Participants will be a family member or close friend of someone who has been diagnosed with early-onset dementia and owns/has a close relationship with a pet.  It is up to you to decide whether or not to take part. If you do decide to take part you will be given an  information sheet to keep and be asked to sign a consent form. If you decide to take part you are still free to withdraw at any time up to 14 days after the interview has taken place without giving a reason. In order to withdraw, participants simply email the lead researcher and state they wish to withdraw. All participants will be required to do is take part in a semi-structured interview which will take place online using Microsoft teams and should take no longer than 60 minutes. All participants will have the option to have their camera on during the call otherwise only their audio will be recorded. The data will be anonymous and will be kept in a password protected OneDrive account. After the interview participants will not be required to do anything else for the study. By taking pet in this study participants will be helping to further the research into how to manage early-onset dementia which will hopefully be helpful to people in the future who find themselves in a position where either themselves, or someone close to them has been given this diagnosis.

If you are interested in taking part please contact Isla Scullion at B00374877@studentmail.uws.ac.uk.

Read more SDRC Latest

Alzheimer Disease International Clinician Survey

This year Alzheimer's Disease International has commissioned McGill University, Montreal, Canada to produce this year's World Alzheimer Report on diagnosis, as well as the 2022 World Alzheimer Report on post-diagnostic support. The first of three surveys is now ready...

Life Sciences Event with the SDRC, SULSA, Brain Health Scotland & Alzheimer Scotland

On the 26-27 May 2022, the Scottish Universities Life Sciences Alliance (SULSA), the Scottish Dementia Research Consortium, Brain Health Scotland and Alzheimer Scotland hosted world leaders in Life Sciences at a summit at the University of St Andrews.  This two-day...

Save the Date: SDRC Annual Conference 2023

The SDRC are pleased to announce the confirmed dates for the Conference 2023. The Conference will take place on 25th & 26th April 2023, the the Radisson Blu Glasgow. Tickets are not yet available, but rest assured that we will keep members updated via the website,...

The launch of the SDRC Annual Report 2019/20

The SDRC Annual Report 2019/20, launched on Monday 20th April, outlines what is new in dementia and brain health research in Scotland in the past 12 months. Once again, we are able to show the truly amazing quantity, quality and diversity of research happening...

The launch of the SDRC Annual Report 2020/21

The SDRC Annual Report 2020/21, launched at the SDRC Annual Conference 2021 on Wednesday 16th June. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. Of course, it heavily features the impact COVID has...

RCPsych Awards 2021: Nominations for Dr Tom Russ and Dr Lucy Stirland

At the SDRC, we are always excited when we can share success of dementia and brain health researchers working in Scotland. We'd like to offer our congratulations to Dr Lucy Stirland and SDRC Executive Committee Member Dr Tom Russ for their recent nominations for a...

Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Dr Terry Quinn explains approval of new Alzheimer's disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the treatment of...

Funding Opportunity: Alzheimer Scotland Student Research Programme

Alzheimer Scotland is pleased to announce the launch of the Student Research Programme. Alzheimer Scotland, with support of the Scottish Dementia Research Consortium (SDRC), is establishing a new research programme, which will fund studentships for projects for...

Take part in a research study: Remote Cognitive Testing Survey

The University of Oxford are looking for volunteers from Scotland to take part in a survey about the Impact of COVID-19 on cognitive testing  The Translational Neuropsychology Lab at the University of Oxford, are investigating the impacts of COVID-19 UK lockdown on...

Neuroprogressive and Dementia Research Network Conference 2022

This year's Neuroprogressive and Dementia Network (from NHS Research Scotland) Annual Conference will be day focused on those most impacted by research outcomes, and an opportunity to learn from their experiences to improve the research landscape. It will bring...